216 related articles for article (PubMed ID: 18161635)
1. In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product.
Nair A; Gupta R; Vasanti S
Pharm Dev Technol; 2007; 12(6):621-5. PubMed ID: 18161635
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.
Sahoo J; Murthy PN; Biswal S; Sahoo SK; Mahapatra AK
AAPS PharmSciTech; 2008; 9(2):577-82. PubMed ID: 18459050
[TBL] [Abstract][Full Text] [Related]
3. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
Park JB; Lim J; Kang CY; Lee BJ
Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
[TBL] [Abstract][Full Text] [Related]
4. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
Khanvilkar KH; Huang Y; Moore AD
Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of gastroretentive controlled release tablets of alfuzosin hydrochloride.
Rudraswamy-Math NR; Gupta VR
Pak J Pharm Sci; 2015 Nov; 28(6):2147-52. PubMed ID: 26639508
[TBL] [Abstract][Full Text] [Related]
6. Zero-order delivery of a highly soluble, low dose drug alfuzosin hydrochloride via gastro-retentive system.
Liu Q; Fassihi R
Int J Pharm; 2008 Feb; 348(1-2):27-34. PubMed ID: 17850997
[TBL] [Abstract][Full Text] [Related]
7. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
Ravi PR; Ganga S; Saha RN
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
[TBL] [Abstract][Full Text] [Related]
8. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
9. Formulation and in vitro studies of a fixed-dose combination of a bilayer matrix tablet containing metformin HCl as sustained release and glipizide as immediate release.
Mandal U; Pal TK
Drug Dev Ind Pharm; 2008 Mar; 34(3):305-13. PubMed ID: 18363146
[TBL] [Abstract][Full Text] [Related]
10. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet.
Park C; Lee JH; Jin G; Ngo HV; Park JB; Tran TTD; Tran PHL; Lee BJ
Curr Drug Deliv; 2022; 19(5):520-533. PubMed ID: 34420504
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
Pradhan R; Kim YI; Chang SW; Kim JO
Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
[TBL] [Abstract][Full Text] [Related]
12. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
Hiremath PS; Saha RN
Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
[TBL] [Abstract][Full Text] [Related]
13. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
Wang MY; Yang YP; Chang JB; Guo MT
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):742-8. PubMed ID: 23073585
[TBL] [Abstract][Full Text] [Related]
14. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
[TBL] [Abstract][Full Text] [Related]
15. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
Saravanan M; Sri Nataraj K; Ganesh KS
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
[TBL] [Abstract][Full Text] [Related]
16. Design and study of lamivudine oral controlled release tablets.
Ravi PR; Ganga S; Saha RN
AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522
[TBL] [Abstract][Full Text] [Related]
17. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro evaluation of controlled release hydrophilic matrix tablets of ketorolac tromethamine using factorial design.
Genç L; Jalvand E
Drug Dev Ind Pharm; 2008 Aug; 34(8):903-10. PubMed ID: 18686094
[TBL] [Abstract][Full Text] [Related]
19. Development and Evaluation of Compression Coating Gastro-Floating Tablet of Alfuzosin Hydrochloride for Zero-Order Controlled Release.
Gong L; Sun Y; Yu M; Gao Y; Zou M; Cheng G
AAPS PharmSciTech; 2018 Oct; 19(7):3277-3286. PubMed ID: 30215168
[TBL] [Abstract][Full Text] [Related]
20. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
